Glenmark Pharmaceuticals Inc. USA has received final approval from the Food and Drug Administration for lidocaine ointment 5%. Glemark said its product is a generic version of Xylocaine ointment 5% from AstraZeneca.
Amneal Pharmaceuticals LLC has expanded its portfolio of women’s health products with the release of Femynor, a birth control pill. Amneal said Femynor (norgestimate and ethinyl estradiol tablets, 0.25 mg/0.
Upsher-Smith Laboratories Inc. has launched a new savings and support program for Qudexy XR extended-release capsules, a once-daily, broad-spectrum anti-epileptic medication.
Again this year, Walgreens is working with the U.S. Department of Health and Human Services (HHS) to provide more than $10 million of free flu shot vouchers for the upcoming flu season.
The National Community Pharmacists Association has endorsed new legislation designed to raise transparency and accuracy in Medicare Part D prescription drug spending and reporting. NCPA said the bill, the Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.
Surescripts is expanding to support population health management with its Medication History for Panel Management service.
Nancy Gagliano, a former senior vice president at CVS Health and chief medical officer of MinuteClinic, has been named chief medical officer at Culbert Healthcare Solutions, a management consulting firm serving health care organizations. Woburn, Mass.
Dr. Reddy’s Laboratories Ltd. has launched bupropion HCl extended-release tablets, an antidepressant medication. Dr.
Walmart’s health and wellness division is poised to play a prominent part in the discounter’s ambitious drive to reinvent retail for an era when brick-and-mortar stores coexist with e-commerce. Pharmacy, over-the-counter medications and vision care currently account for about 10% of Walmart’s U.S.
The pullback of health insurance companies from the Affordable Care Act has focused a harsh light on President Obama’s signature legislative achievement. Most recently, Aetna Inc.
Lars Rebien Sørensen, president and chief executive officer of Novo Nordisk A/S, is retiring from the company and will be succeeded by Lars Fruergaard Jørgensen. Plans call for Jørgensen, executive vice president and head of corporate development, to take the CEO reins on Jan.
Citing dangers from combined use, the Food and Drug Administration is requiring classwide changes to labeling for opioid analgesics, prescription opioid cough products and benzodiazepines, a group of central nervous system depressant drugs.
Impax Laboratories Inc. is spotlighting its generic epinephrine auto-injector amid a public outcry over the cost of emergency medication for anaphylaxis, a potentially life-threatening allergic reaction.
Express Scripts has unveiled a program designed to rein in drug spending for diabetes patients. The pharmacy benefit manager on Wednesday launched the Diabetes Care Value Program, which the company said improves pharmacy care and controls plan costs for people with diabetes.
Albertsons Cos. has begun offering flu shots on a walk-in basis at its more than 1,700 supermarket pharmacy locations.
Greenstone LLC has introduced nitroglycerin sublingual tablets, a medication for chest pain. The Pfizer subsidiary said Monday that its product is an authorized generic version of Nitrostat and comes in dosages of 0.3 mg (100 count), 0.4 mg (100 count) and 0.6 mg (100 count).
